Buy Yasmin

Yasmin

What is Yasmin?

Yasmin is a prescription oral contraceptive that combines two synthetic hormones: drospirenone (a progestin) and ethinyl estradiol (an estrogen). It is marketed as a combined oral contraceptive pill (COCP) in a single-dose tablet containing 3 mg drospirenone and 0.03 mg ethinyl estradiol. In Hong Kong, Yasmin is regulated by the Department of Health and is available only with a physician’s prescription. The pill is taken once daily for 21 consecutive days followed by a 7-day pause (or placebo pills), during which a withdrawal bleed typically occurs.

How Yasmin Works in the Body

Yasmin prevents pregnancy through three complementary mechanisms:

• Suppression of ovulation - The estrogen component stabilises the hormonal feedback loop, while the progestin component blocks the surge of luteinising hormone (LH) that triggers ovulation.
• Thickening of cervical mucus - Drospirenone makes the cervical mucus more viscous, hindering sperm penetration.
• Endometrial transformation - The hormone mixture keeps the uterine lining thin, reducing the likelihood of implantation should fertilisation occur.

The hormonal effects begin within the first 24 hours of the first pill and reach maximal suppression after several days of continuous use. Because both hormones are absorbed orally, the onset of action is rapid, but steady-state plasma concentrations are achieved after about a week of daily dosing.

Conditions Treated by Yasmin

Yasmin is approved in Hong Kong for the following indications:

• Prevention of pregnancy in women of reproductive age who are not breastfeeding.
• Management of menstrual disorders such as dysmenorrhoea (painful periods) and irregular bleeding when used as directed by a healthcare professional.

These uses are supported by regulatory reviews from the US Food and Drug Administration (FDA) and the European Medicines Agency (EMA), which are also referenced by Hong Kong’s health authorities.

Evidence-Based Off-Label Uses

• Premenstrual Dysphoric Disorder (PMDD). Clinical trials have demonstrated that drospirenone-containing COCPs can reduce the severity of PMDD symptoms. This use is not formally approved by the Hong Kong Department of Health, so it requires medical supervision and an individualized risk assessment.
• Acne vulgaris. The anti-androgenic activity of drospirenone improves acne in many women. Though effective, prescribing for acne alone is considered off-label and should be discussed with a dermatologist or primary care provider.

Disclaimer: Off-label use of any medication must be overseen by a qualified healthcare professional.

Who Should (Not) Use Yasmin?

Absolute Contra-indications

• Known or suspected pregnancy.
• History of thromboembolic events (deep-vein thrombosis, pulmonary embolism, stroke).
• Uncontrolled hypertension (systolic ≥ 160 mmHg or diastolic ≥ 100 mmHg).
• Severe liver disease (e.g., cirrhosis, hepatic adenoma).
• Breast cancer or other estrogen-dependent tumours.
• Known hypersensitivity to drospirenone, ethinyl estradiol, or any excipients in the tablet.

Relative Contra-indications

• Women over 35 years who smoke any amount of tobacco.
• Migraine with aura or other vascular headaches.
• Diabetes with microvascular complications.
• Obesity (BMI ≥ 30 kg/m²), which modestly increases clot-risk.
• Use of CYP3A4-inducing medications (e.g., certain anticonvulsants, rifampicin) that may lower contraceptive efficacy.

Special Populations

• Pregnancy & lactation: Yasmin must be discontinued immediately if pregnancy is confirmed. It is not recommended during breastfeeding.
• Adolescents: Can be prescribed after careful assessment of maturity and adherence capability.
• Elderly women: Not typically indicated; risks generally outweigh benefits after menopause.

Safety Profile: Side Effects and Interactions

Common Side Effects

• Nausea or mild gastrointestinal discomfort.
• Breast tenderness or enlargement.
• Headache, mild dizziness.
• Changes in menstrual bleeding pattern (spotting, breakthrough bleeding).
• Mood swings or mild depression.

These effects are usually transient and improve within the first few cycles.

Serious Adverse Events

• Venous thromboembolism (VTE): Deep-vein thrombosis, pulmonary embolism - seek urgent medical care if leg swelling, pain, or sudden shortness of breath occur.
• Arterial thrombosis: Stroke or myocardial infarction - immediate emergency attention required for sudden neurological deficits or chest pain.
• Hyperbilirubinemia or severe liver dysfunction.
• Allergic reaction (rash, angioedema, anaphylaxis).

Yasmin carries a black-box warning for thromboembolic risk, consistent with all combined oral contraceptives.

Drug Interactions

• CYP3A4 inducers (e.g., rifampicin, carbamazepine, phenytoin, St. John’s wort) can reduce hormone levels, increasing the chance of contraceptive failure.
• Antiepileptics (e.g., topiramate) and some antiretrovirals may also diminish efficacy.
• Antifungals like ketoconazole can increase hormone concentrations, potentially raising side-effect risk.
• Lithium and certain antibiotics have limited evidence of interaction, but caution is advised.

Patients should provide a full medication list-including over-the-counter drugs, supplements, and herbal products-to their prescriber.

Food and Lifestyle Interactions

• Yasmin may be taken with or without food; however, consistent timing each day improves adherence.
• Grapefruit juice can modestly inhibit CYP3A4, possibly raising hormone levels - limit excessive consumption.
• Alcohol does not affect effectiveness but may worsen certain side effects (e.g., headache, nausea).
• Driving or operating machinery: No impairment is expected, but severe dizziness warrants caution.

How to Take Yasmin

• Standard regimen: One tablet daily for 21 days, followed by a 7-day pill-free interval (or placebo tablets).
• Starting the pack:
• If beginning within the first 5 days of a menstrual period, protection begins immediately.
• If starting at any other time, use a reliable backup method (e.g., condom) for the first 7 days.
• Missed dose:
• If a single pill is missed and it’s been < 24 hours, take it as soon as remembered, then continue with the next pill at the usual time.
• If ≥ 2 consecutive pills are missed, take the most recent missed pill immediately, discard any other missed pills, and use additional contraception for the next 7 days.
• Never double-dose to catch up.
• Overdose: Symptoms may include nausea, vomiting, and breast tenderness. Seek emergency medical assistance; there is no specific antidote.
• Discontinuation: No tapering is required. If stopping for any reason, use an alternative contraceptive method immediately to avoid unintended pregnancy.

Monitoring and Follow-Up

• Blood pressure should be measured before starting Yasmin and periodically (e.g., annually).
• Weight and BMI are monitored, especially in women with obesity.
• Screen for VTE risk factors (family history, prolonged immobilisation).
• Periodic gynecologic assessment to evaluate bleeding patterns and overall tolerability.
• Laboratory tests are not routinely required, but liver function tests may be ordered if pre-existing liver disease is suspected.

Storage and Handling

• Store Yasmin tablets at room temperature (15 °C-30 °C), away from excess moisture and direct sunlight.
• Keep the bottle tightly closed and out of reach of children.
• Do not use tablets after the printed expiration date.
• If a tablet becomes discoloured or damaged, discard it and obtain a replacement from a pharmacy.

Medication-Specific Glossary

Combined oral contraceptive (COCP)

A single tablet that contains both an estrogen and a progestin, used primarily for preventing pregnancy.

Thromboembolism

Formation of a blood clot (thrombus) that can travel through the bloodstream and obstruct a vessel (embolism), potentially causing serious conditions such as stroke or pulmonary embolism.

CYP3A4

An enzyme in the liver and intestinal wall that metabolises many drugs, including the hormones in Yasmin; substances that induce or inhibit this enzyme can alter contraceptive effectiveness.

Medical Disclaimer

This article provides educational information about Yasmin and is not a substitute for professional medical advice. Treatment decisions, including use for unapproved indications, must be made under the guidance of a qualified healthcare provider. The content is intended for informational purposes and does not constitute medical recommendations. Always consult a physician before starting, stopping, or changing any medication regimen.